The COVID-19 vaccine developed by Oxford University and AstraZeneca is not likely to be authorized for emergency use in the United States until April 2021, Operation Warp Speed’s chief scientific adviser Moncef Slaoui said Wednesday.
“We project, if everything goes well, that the readout and emergency use authorization may be granted somewhere early in the month of April,” Slaoui told reporters during a briefing with senior officials on the nation’s COVID-19 vaccine program.
